image by: HWN

HWN Suggests

GRACE Guidelines: A Pragmatic Approach to Recurrent Low-Risk Chest Pain

These guidelines are comprehensive and pragmatic. However, they highlight how little evidence exists on recurrent low-risk chest pain and patient values and preferences for low-risk recurrent chest pain treatment. This lack of data represents an opportunity for future research to illuminate some gaps in knowledge. Also, of worthy discussion, some hospitals do not have high-sensitivity troponins. Therefore, some guidelines may not be applicable in all clinical settings. Likewise, expedited outpatient follow-up may also be difficult for some. Underinsured and uninsured patients are particularly vulnerable to follow-up loss. Accordingly, we often practice more cautiously with patients with limited…

read full article

Featured

 Amazing GRACE-1 How Sweet the Guidelines – Recurrent, Low Risk Chest Pain in the Emergency Department

The application of this GRACE-1 clinical practice guideline depends on many factors. This includes: where you work, personal risk tolerance, patient values/preferences/risk tolerances, regional practices/testing capabilities, which troponin test you have in your hospital, and other things.

Articles of Interest

Comparing TIMI, HEART, and GRACE Risk Scores to Predict Angiographic Severity of Coronary Artery Disease and 30-Day Major Adverse Cardiac Events in Emergency Department Patients with NSTEACS

The ability of the GRACE, HEART, and TIMI risk scores to predict severe CAD in patients with NSTEACS is similar. In patients with NSTEACS, the HEART and GRACE risk scores can better predict the development of MACE than the TIMI risk score. When low-risk groups are evaluated according to the three risk scores, the HEART score is more reliable to exclude the diagnosis of NSTEACS.

Determining Your Risk: The GRACE Score and Treatment Timing

Research has shown that for those with a high GRACE score, getting to the lab early can reduce the chance of recurrent ischemia. Conversely, for those with a low risk, rushing into a procedure doesn’t always provide a benefit and may even increase the risk of bleeding or other complications

Effectiveness of GRACE risk score in patients admitted to hospital with non-ST elevation acute coronary syndrome (UKGRIS):

In adults presenting to hospital with suspected non-ST elevation acute coronary syndrome, the GRS did not improve adherence to guideline recommended management or reduce cardiovascular events at 12 months.

Global Registry of Acute Coronary Events Score Underestimates Post-Acute Coronary Syndrome Mortality among Cancer Patients

This study showed that although the GRACE score was more accurate in patients without cancer, it greatly underestimated the risk of death in patients with previous cancer. Specific risk stratification scores are required for patients with previous cancer who have a heart attack.

GRACE 3.0

The Global Registry of Acute Coronary Events (GRACE) score is the most established scoring system for risk prediction and risk stratification in patients with acute coronary syndrome. It can be calculated from widely available clinical, electrocardiographic, and biochemical patient variables. The improved GRACE 3.0 scoring system has been developed and broadly validated in over 600.000 patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) using machine learning approaches.

Using the GRACE Risk Scores in Everyday Practice

Acute coronary syndromes, a continuum of disease ranging from unstable angina to ST-elevation myocardial infarction, can pose a high degree of uncertainty and acuity on presentation. These patients have varying degrees of risk for death and adverse events. The recently released 2011 Focused Update on the American College of Cardiology and American Heart Association Guidelines for the Management of Unstable Angina and Non-ST Elevation Myocardial Infarction suggest that using a risk-stratification tool can not only help clinicians with prognostication, but also may help them decide which patients warrant higher-risk interventional strategies such as anticoagulation or cardiac catheterization.

Validity of the GRACE (Global Registry of Acute Coronary Events) acute coronary syndrome prediction model for six month post‐discharge death in an independent data set

In an independent validation the GRACE risk model had good discriminatory capacity for predicting post‐discharge death at six months and was generally well calibrated, suggesting that it is suitable for clinical use in general populations.

Resources

GRACE ACS Risk and Mortality Calculator

The GRACE Score (2.0) can be used in patients with acute coronary syndrome using commonly obtained clinical variables. It can support risk stratification for an early invasive strategy. For patients with STEMI, it can provide prognostic information but should not delay reperfusion. Always interpret this score with troponin values, ECG, and clinical judgement.